Anti-FcgR3a / CD16a (AFM13)

Anti-FcgR3a / CD16a (AFM13) is a tetravalent bispecific antibody directed against human CD30 and the human low affinity IgG Fc region receptor (FCGR3A; CD16A), with potential immunomodulating and antineoplastic activities. MW: 143.56 kD.
Supplier Selleck Chemicals
Product # A2750
Sku # A2750-1mg*25
Pricing 1mg*25, $5070.00
Feedback